Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Global Anticancer Drug Market Outlook,Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023

  • Report Summary
  • Free Analysis
  • Table of Contents
  • Enquiry Before Buying

Report Summary

The global anticancer drug market is expected to increase from USD 92.1 billion in 2016 to USD 145.2 billion in 2023, at a CAGR of 6.7% from 2017 to 2023. The growth of the anticancer drug market across the globe is attributed to growing awareness towards cancer diagnosis and treatment, and increasing incidence of targeted disease (lungs cancer, oral cancer, and skin cancer among others), coupled with increasing research and development activity. The years used for the assessment are as follows;

Historical year: 2013, 2014, 2015

Base year: 2016

Forecast period: 2017 – 2023

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year Impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the total anticancer drug market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global anticancer drug market
  • Finalizing the overall size and shareof the global anticancer drug market

OBJECTIVES:

  • To classify the global anticancer drug market into segments on the basis of drug type, therapy, and cancer types and analyze their growth prospects individually
  • To analyze market trends, opportunities, drivers, and restraints associated with the anticancer drug market
  • To study market response with respect to the mergers and acquisitions in the industry
  • To profile key companies operating in the anticancer drug market and provide their competitive landscape 

MARKET SCOPE

The research scope for anticancer drug market is as follows:

By Drugs Type

  • Targeted Drugs
  • Cytotoxic Drugs
  • Hormonal Drugs

By Therapy

  • Immunotherapy
  • Targeted Therapy
  • Chemotherapy
  • Hormonal Therapy
  • Others

By Cancer Types

  • Breast Cancer
  • Bone Marrow Cancer
  • Blood Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Skin Cancer
  • Lung Cancer
  • Oral Cancer
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Free Analysis

Global Anticancer Drug market is expected to grow from USD 92.1 billion in 2016 to USD 145.2 billion by 2023, at a CAGR of 6.7% from 2017 to 2023. The growth of the anticancer drug market is attributed to the growing awareness towards cancer diagnosis and treatment, and increasing incidence of targeted disease (lungs cancer, skin cancer, and oral cancer among others),coupled with increasing research and development activity. However, high prices of treatment may hamper the growth of the global anticancer drug market.

Cancer is a major health problem worldwide and the second leading cause of death globally. It is an unwanted growth of abnormal cells that grow beyond their boundary. These abnormal cells are called cancer cells, or tumor cells.

Based on the drugs types, the targeted drugs held the major share of the global anticancer drug market in 2016 and is expected to retain its dominance during the forecast period owing to the new drug development, and using different nano-systems to treat particular types of cancer. On the basis of therapy, the targeted therapy hold the major share of the global anticancer drug market, owing to the approval of U.S. Food and Drug Administration (FDA) for targeted therapies of many types of cancers, coupled with increasing incidence of targeted disease such as gastrointestinal cancer, breast cancer, lungs cancer,  prostate cancer and among others.

North America held the major share of the global anticancer drug market in 2016 due to growing awareness among people, coupled with increasing advancement in research and development activity. Europe is the second largest market of the global anticancer drug market. The factor driving the growth is increasing incidence of targeted disease such as lungs cancer, skin cancer, and oral cancer and among others. Growth of the anticancer drug market in Asia-Pacific is owing to the increasing number of the cancer patient, coupled with much consumption of tobacco and alcohol.

The key players dealing in the anticancer drug market are Roche Holding Ltd, Celgene, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Novartis, AstraZeneca, Teva Pharmaceutical, Eli Lilly, Bayer, and GlaxoSmithKline among others.

Table of Contents

TABLE OF CONTENTS

CHAPTER 1. Market Scope and Methodology

1.1. Market Definition

1.2. Market Segmentation

1.2.1. Market Breakdown, By Drugs Types

1.2.2. Market Breakdown, By Therapy

1.2.3. Market Breakdown, By Cancer Types

1.2.4. Market Breakdown, By Region

1.3. Research Methodology

1.3.1. Initial Data Search

1.3.2. Secondary Research

1.3.3. Primary Research

1.3.4. Scope and Assumptions

1.4. Sources

1.5. Executive Summary

CHAPTER 2. Market Outlook

2.1. Introduction

2.2. Market Outlook

2.2.1. Opportunities

2.2.1.1. Supporting government initiative to raise awareness and improve health services

2.2.1.2. Extensive research and development for discovery of new drugs

2.2.2. Trends

2.2.2.1. Increasing research and development activity on targeted and biological drug therapy

2.2.2.2. Government and private funding support to the cancer treatment

2.2.3. Growth Drivers

2.2.3.1. Adoption of advanced technology in cancer treatment across the globe

2.2.3.2. Growing expenditure in healthcare sector in developing nations

2.2.3.3. Technology supporting specific target for cancer treatments

2.2.4. Impact Analysis of Drivers on Future Forecast of the Market

2.2.5. Restraints of the Market

2.2.5.1. Adverse effect of drugs

2.2.5.2. High cost of treatment

2.2.6. Impact Analysis of Restraints on Future Forecast of the Market

CHAPTER 3. Market Entry Strategy

3.1. PESTLE Analysis

3.2. Value Chain Analysis

3.3. Competitive Analysis

3.3.1. Company Market Share Analysis

3.3.2. Porter’s Five Forces Analysis

CHAPTER 4. Global Anticancer Drug Market Size and Forecast (2013 – 2023)

4.1. Global Anticancer Drug Market, By Drugs Types

4.1.1. Targeted Drugs

4.1.2. Cytotoxic Drugs

4.1.3. Hormonal Drugs

4.2. Global Anticancer Drug Market, By Therapy

4.2.1. Immunotherapy

4.2.2. Targeted Therapy

4.2.3. Chemotherapy

4.2.4. Hormonal Therapy

4.2.5. Others

4.3. Global Anticancer Drug Market, By Cancer Types

4.3.1. Breast Cancer

4.3.2. Bone Marrow Cancer

4.3.3. Blood Cancer

4.3.4. Gastrointestinal Cancer

4.3.5. Prostate Cancer

4.3.6. Skin Cancer

4.3.7. Lung Cancer

4.3.8. Oral Cancer

4.3.9. Others

4.4. Global Anticancer Drug Market, By Region

4.4.1. North America

4.4.2. Latin America

4.4.3. Europe

4.4.4. Asia-Pacific

4.4.5. Middle East and Africa

CHAPTER 5. Global Anticancer Drug Market, By Geography

5.1. North America Anticancer Drug Market

5.1.1. North America Anticancer Drug Market, By Drugs Types (USD Billion)

5.1.2. North America Anticancer Drug Market, By Therapy (USD Billion)

5.1.3. North America Anticancer Drug Market, By Cancer Types (USD Billion)

5.1.4. North America Anticancer Drug Market, By Country

5.1.4.1. The U.S.

5.1.4.2. Canada

5.1.4.3. Mexico

5.1.4.4. Rest of North America

5.1.4.4.1. Rest of North America Anticancer Drug Market, By Drugs Types (USD Billion)

5.1.4.4.2. Rest of North America Anticancer Drug Market, By Therapy (USD Billion)

5.1.4.4.3. Rest of North America Anticancer Drug Market, By Cancer Types (USD Billion)

5.2. Latin America Anticancer Drug Market

5.2.1. Latin America Anticancer Drug Market, By Drugs Types (USD Billion)

5.2.2. Latin America Anticancer Drug Market, By Therapy (USD Billion)

5.2.3. Latin America Anticancer Drug Market, By Cancer Types (USD Billion)

5.2.4. Latin America Anticancer Drug Market By Country

5.2.4.1. Argentina

5.2.4.2. Brazil

5.2.4.3. Colombia

5.2.4.4. Rest of Latin America

5.2.4.4.1. Rest of Latin America Anticancer Drug Market, By Drugs Types (USD Billion)

5.2.4.4.2. Rest of Latin America Anticancer Drug Market, By Therapy (USD Billion)

5.2.4.4.3. Rest of Latin America Anticancer Drug Market, By Cancer Types (USD Billion)

5.3. Europe Anticancer Drug Market

5.3.1. Europe Anticancer Drug Market, By Drugs Types (USD Billion)

5.3.2. Europe Anticancer Drug Market, By Therapy (USD Billion)

5.3.3. Europe Anticancer Drug Market, By Cancer Types (USD Billion)

5.3.4. Europe Anticancer Drug Market, By Country

  5.3.4.1. Germany

  5.3.4.2. France

  5.3.4.3. The U.K.

  5.3.4.4. Italy

  5.3.4.5. Spain

  5.3.4.6. France

  5.3.4.7. Monaco

  5.3.4.8. Estonia

5.3.5. Rest of Europe

5.3.5.1. Rest of Europe Anticancer Drug Market By Drugs Types (USD Billion)

5.3.5.2. Rest of Europe Anticancer Drug Market, By Therapy (USD Billion)

5.3.5.3. Rest of Europe Anticancer Drug Market, By Cancer Types (Billion)

5.4. Asia-Pacific Anticancer Drug Market

5.4.1. Asia-Pacific Anticancer Drug Market, By Drugs Types (USD Billion)

5.4.2. Asia-Pacific Anticancer Drug Market, By Therapy (USD Billion)

5.4.3. Asia-Pacific Anticancer Drug Market, By Cancer Types (USD Billion)

5.4.4. Asia-Pacific Anticancer Drug Market, By Country

5.4.4.1. China

5.4.4.2. Japan

5.4.4.3. Australia

5.4.4.4. India

5.4.4.5. South Korea

5.4.4.6. New Zealand

5.4.4.7. Rest of Asia-Pacific

5.4.4.7.1. Rest of Asia-Pacific Anticancer Drug Market, By Drugs Types (USD Billion)

5.4.4.7.2. Rest of Asia-Pacific Anticancer Drug Market, By Therapy (USD Billion)

5.4.4.7.3. Rest of Asia-Pacific Anticancer Drug Market, By Cancer Types (USD Billion)

5.5. Middle East and Africa Anticancer Drug Market

5.5.1. Middle East and Africa Anticancer Drug Market, By Drugs Types (USD Billion)

5.5.2. Middle East and Africa Anticancer Drug Market, By Therapy (USD Billion)

5.5.3. Middle East and Africa Anticancer Drugs Market, By Cancer Types (Billion)

5.5.4. Middle East and Africa Anticancer Drug Market, By Country

5.5.4.1. Egypt

5.5.4.2. Nigeria

5.5.4.3. Ethiopia

5.5.4.4. Iran

5.5.4.5. Rest of Middle East and Africa

5.5.4.5.1. Rest of Middle East and Africa Anticancer Drug Market, By Drugs Types (USD Billion)

5.5.4.5.2. Rest of Middle East and Africa Anticancer Drug Market, By Therapy (USD Billion)

5.5.4.5.3. Rest of Middle East and Africa Anticancer Drug Market, By Cancer Types (USD Billion)

CHAPTER 6. Key Players and Strategic Developments

6.1. Roche

6.1.1. Business Overview

6.1.2. Product and Service Offering

6.1.3. Financial Overview

6.1.4. Strategic Developments

6.2. Celgene

6.2.1. Business Overview

6.2.2. Product and Service Offering

6.2.3. Financial Overview

6.2.4. Strategic Developments

6.3. Johnson & Johnson

6.3.1. Business Overview

6.3.2. Product and Service Offering

6.3.3. Financial Overview

6.3.4. Strategic Developments

6.4. Pfizer

6.4.1. Business Overview

6.4.2. Product and Service Offering

6.4.3. Financial Overview

6.4.4. Strategic Developments

6.5. Bristol-Myers Squibb

6.5.1. Business Overview

6.5.2. Product and Service Offering

6.5.3. Financial Overview

6.5.4. Strategic Developments

6.6. Novartis

6.6.1. Business Overview

6.6.2. Product and Service Offering

6.6.3. Financial Overview

6.6.4. Strategic Developments

6.7. AstraZeneca

6.7.1. Business Overview

6.7.2. Product and Service Offering

6.7.3. Financial Overview

6.7.4. Strategic Developments

6.8. Teva Pharmaceuticals

6.8.1. Business Overview

6.8.2. Product and Service Offering

6.8.3. Financial Overview

6.8.4. Strategic Developments

6.9. Eli Lilly

6.9.1. Business Overview

6.9.2. Product and Service Offering

6.9.3. Financial Overview

6.9.4. Strategic Developments

6.10. Bayer

6.10.1. Business Overview

6.10.2. Product and Service Offering

6.10.3. Financial Overview

6.10.4. Strategic Developments

6.11. GlaxoSmithKline

6.11.1. Business Overview

6.11.2. Product and Service Offering

6.11.3. Financial Overview

6.11.4. Strategic Developments

6.12. Abbreviation

Enquiry Before Buying

[contact-form-7]

Global Anticancer Drug Market Outlook,Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation Forecast 2023

Related Reports

  • Global Intra-Uterine Contraceptive Device Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023
    January 31, 2018
  • Global Telemedicine Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023
    January 25, 2018
  • Global Protein Purification and Isolation Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023
    January 10, 2018
  • Global Microbial Identification Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023
    December 30, 2017

The post Global Anticancer Drug Market Outlook,Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023 appeared first on Energias Market Research.



This post first appeared on Market Research Reports, Market Analysis, Market Survey, please read the originial post: here

Share the post

Global Anticancer Drug Market Outlook,Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2023

×

Subscribe to Market Research Reports, Market Analysis, Market Survey

Get updates delivered right to your inbox!

Thank you for your subscription

×